Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Cue Health Inc. HLTHQ

Healthcare — Health Information Services

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership
26.72%

Capital & Financial Ratios

Market Cap
6.90
Revenue
70.94
Net Income
(373.46)
Free Cash Flow
(157.61)
Net Debt
(81.69)
Current Ratio
2.54
Debt/Equity
0.00
P/E ratio
0.00
P/S ratio
0.00
P/B ratio
0.00
Past 5Y EPS Growth
(103.84%)
This Y EPS Growth
52.00%
Next Y EPS Growth
44.05%
Next 5Y EPS Growth
—
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
—
Annual Dividend Yield
—
total individual payouts
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
2020 ‡‡‡
2019 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2020 2021 2022 2023
Cash 127.58 423.71 242.33 81.69
Receivables 4.17 104.59 18.75 1.35
Inventory 36.84 88.39 82.21 14.04
Other 1.26 7.45 12.13 4.80
183.70 670.02 371.15 110.36
2020 2021 2022 2023
Payables 23.85 37.21 7.15 7.71
ST’ Debt 5.43 9.77 10.10 —
Other 124.57 111.66 53.94 —
155.90 166.94 71.20 43.47
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — ‡‡‡‡‡
Cash Flow — — ‡‡‡
Earnings — — ‡‡‡
Book Value — — ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 — — — —
—
’23 24.77 9.90 17.48 18.80
70.94
’22 179.41 87.70 69.59 146.78
483.48
’21 64.50 137.42 223.68 192.51
618.11
’20 0.61 4.35 4.73 —
22.95
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 — — — —
—
’23 (53.88) (42.66) (12.54) (28.72)
(137.81)
’22 31.52 (51.83) (39.91) (51.70)
(111.92)
’21 (35.11) (2.70) 19.51 8.85
(9.45)
’20 (7.67) (13.34) (59.24) 151.90
92.66
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 — — — —
—
’23 (62.20) (48.65) (16.20) (30.55)
(157.61)
’22 17.47 (72.46) (58.17) (61.78)
(174.95)
’21 (66.95) (29.75) 0.25 (28.71)
(125.17)
’20 (7.67) (13.34) (66.25) 80.76
14.51
in millions of $

EPS

Mar Jun Sep Dec Year
’26 — — — —
—
’23 (0.62) (0.55) (0.31) (0.96)
(2.44)
’22 0.02 (0.67) (0.45) (0.21)
(1.31)
’21 0.01 0.02 0.13 0.22
0.59
’20 (0.06) (0.07) (0.06) —
(0.33)

Target Price Range

High
‡‡‡‡‡
‡‡‡
Average
‡‡‡‡‡
‡‡‡
Low
‡‡‡‡‡
‡‡‡

Recommendation Rating

1
1
Buy
2
3
Hold
4
5
Sell
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
— — — — — — — ‡‡‡‡ 1.63 0.16 — — —
Low Price
— — — — — — — ‡‡‡‡‡ 14.90 2.82 — — —
High Price
— — — — — — ‡‡‡‡‡ ‡‡‡‡‡ 1,515 726 — — —
Employees
— — — — — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.32 0.10 — — —
Revenue/Emp
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 483.48 70.94 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
— — — — — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 31.75% (79.16%) — — —
Gross Margin
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (203.80) (368.67) ‡‡‡‡‡ ‡‡‡‡‡ —
EBT
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (42.15%) (519.72%) ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
— — — ‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (194.06) (373.46) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 48.97 56.28 — — —
Depreciation
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.27 0.46 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ (1.31) (2.44) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.76) (0.90) — — —
Cash Flow/Sh
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.43) (0.13) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.18) (1.03) — — —
Free CF/Sh
— — — — — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.89 1.64 ‡‡‡‡ ‡‡‡ ‡‡‡‡
Book Value/Sh
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 148.02 152.88 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
PE Ratio
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.65 0.50 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
— — — — — ‡‡‡ ‡‡‡ ‡‡‡‡‡ 0.55 0.14 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.17 0.05 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
EV/Sales
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.48) (0.02) — — —
EV/FCF
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (111.92) (137.81) ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (63.03) (19.80) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capex
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (174.95) (157.61) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
FCF
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 299.96 66.90 — — —
Working Cap'
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.95 — — — —
Total Debt
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (231.38) (81.69) — — —
Net Debt
— — — — — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 576.49 250.25 — — —
Sh' Equity
— — — — — ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (23.74%) (72.21%) ‡‡‡ ‡‡‡ —
ROA
— — — — — ‡‡‡ ‡‡‡ ‡‡‡‡‡ (37.24%) (146.40%) — — —
ROIC
— — — — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (30.24%) (90.35%) ‡‡‡‡‡ ‡‡‡‡‡ —
ROE
predictions in italic, sparklines do not include predictions

Cue Health Inc. (HLTHQ) Latest News

News by impact score

Fine-tune

10 Jun

4 www.thestreet.com, 7:55 AM
Cue Health Inc. files for Chapter 7 bankruptcy after failing to adapt to declining demand for Covid testing, leading to layoffs and liquidation. Bankruptcy filing and liquidation of Cue Health Inc. are significant events that will have a major impact on the company's future and market performance.

28 May

4 Business Wire, 4:31 PM
Cue Health Inc. files for Chapter 7 bankruptcy to wind down business. The bankruptcy filing is a significant event that will likely have a major impact on Cue Health Inc.'s future and market performance.

22 May

4 www.medtechdive.com, 12:59 PM
Cue Health to lay off all U.S. employees and company leadership due to funding drying up and plummeting demand for COVID tests. The layoffs and warning from the FDA regarding unauthorized changes to their COVID test are significant events that will likely impact Cue Health Inc.'s future and market performance.

14 May

4 www.medicaldevice-network.com, 6:51 AM
FDA warns users not to use Cue Health’s at-home Covid-19 tests. FDA warning on Cue Health's tests could significantly impact company's future and market performance.

4 www.medtechdive.com, 6:00 AM
FDA warns against using Cue Health COVID-19 tests due to increased risk of false results. The FDA warning and potential false results could significantly impact Cue Health Inc.'s future and market performance.

13 May

3 Business Wire, 8:30 PM
Cue Health received a warning letter from the FDA regarding its COVID-19 test. The warning letter from the FDA could moderately influence Cue Health's future operations and market performance.

3 May

4 www.medtechdive.com, 5:00 AM
Cue Health plans to cut 230 employees amid declining COVID-19 test sales. Significant impact likely on future and performance due to major layoffs, declining sales, and leadership changes.

29 Apr

3 Business Wire, 4:01 PM
Cue Health Inc. to release first quarter financial results on May 13, 2024. Financial results announcement may moderately influence Cue Health Inc.'s performance.

20 Mar

4 Business Wire, 5:21 PM
Cue Health Inc. announces strategic actions including appointing Clint Sever as CEO and adding two strategic advisors. The appointment of a new CEO, strategic advisors, and a comprehensive review of the company's business indicate significant strategic moves that could have a significant impact on Cue Health Inc.'s future and market performance.

18 Mar

4 InvestorPlace, 8:49 PM
Cue Health Inc. (HLTH) is one of three penny stocks discussed in the article, with analyst backing and potential upside. The article discusses potential significant impact on Cue Health Inc. (HLTH) future and market performance due to analyst expectations and growth potential.

15 Mar

4 Insider Monkey, 12:53 PM
Cue Health Inc. (HLTH) beats earnings expectations in Q4 2023 with reported EPS of $-0.32. The significant progress and milestones achieved by Cue Health Inc. in 2023, along with cost reduction efforts and menu expansion plans, are likely to have a significant impact on its future performance and market positioning.

13 Mar

4 Business Wire, 4:01 PM
Cue Health Inc. reports fourth quarter 2023 financial results, with revenue of $18.8 million and total revenue of $70.9 million for the full year. The company made progress on strategic priorities, including FDA authorizations and development of new tests. The financial results and strategic progress are significant and likely to impact Cue Health Inc.'s future performance and market positioning.

3 Zacks, 5:10 PM
Cue Health Inc. (HLTH) reports Q4 loss but tops revenue estimates. The article discusses the company's financial performance and future outlook, which may moderately influence its market performance.

28 Feb

3 Business Wire, 4:01 PM
Cue Health Inc. to announce Q4 and full year 2023 financial results on March 13, 2024. Financial results announcement may moderately influence market sentiment and financial performance.

16 Feb

3 Business Wire, 5:00 PM
Cue Health appoints Rishi Reddy to its board of directors. Appointment of a new board member may influence key areas like financial performance and strategic decision-making.

9 Feb

4 www.medtechdive.com, 6:55 AM
Cue Health announced layoffs due to declining COVID-19 test sales. The layoffs and declining sales could significantly impact Cue Health's future and market performance.

31 Jan

3 Business Wire, 4:01 PM
Cue Health to participate at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13, 2024. Participation in the conference may moderately influence Cue Health's market performance and competitive positioning.

30 Jan

4 Simply Wall St., 5:28 AM
Cue Health had a short cash runway of 7 months as of September 2023 due to high cash burn rate. High cash burn rate relative to market cap poses significant risk to company's future.

10 Nov

4 Simply Wall St., 5:07 AM
Cue Health Inc. (NASDAQ:HLTH) shares slump 28% in a rough month, completing a disastrous twelve months with a 92% loss. Significant impact likely on future and performance due to poor revenue performance and low growth expectations.

4 www.medtechdive.com, 12:23 AM
FDA clears first over-the-counter COVID-19 antigen test for Acon Laboratories. The FDA clearance of the over-the-counter COVID-19 antigen test could significantly impact Cue Health Inc.'s future market performance and competitive landscape.

9 Nov

4 Insider Monkey, 10:14 AM
Cue Health Inc. beats earnings expectations with reported EPS of $-0.43, exceeding expectations of $-0.47. Revenue for Q3 2023 was $17.5 million, driven by strong COVID-19 test sales. The article highlights significant developments in Cue Health Inc.'s test menu expansion efforts and financial performance, indicating a potential significant impact on future growth and market performance.

8 Nov

4 GuruFocus.com, 5:59 PM
Cue Health Inc (HLTH) reports Q3 2023 revenue of $17.5 million, surpassing expectations. Significant impact likely on future performance with revenue exceeding expectations and cost savings achieved.

4 Business Wire, 4:01 PM
Cue Health Inc. reports third quarter 2023 financial results, exceeding revenue expectations and achieving cost savings goals. Financial results exceeding expectations and achieving cost savings goals are significant for future performance.

25 Oct

3 Business Wire, 4:01 PM
Cue Health Inc. to announce third quarter 2023 financial results on November 8, 2023. The financial results announcement may moderately influence Cue Health Inc.'s performance.

6 Oct

4 Business Wire, 7:57 PM
Concerned stockholders of Cue Health call for Board to reign in expansion and cut expenditures. The concerns raised by stockholders regarding the company's undisciplined expansion and financial stability could significantly impact Cue Health's future trajectory and investor sentiment.

4 Oct

4 Business Wire, 9:15 AM
Cue Health's molecular COVID-19 test found to be as accurate as lab-based PCR test in largest clinical study on asymptomatic people. The study results are expected to significantly impact Cue Health's future performance and market position due to the high accuracy and convenience of their COVID-19 test.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us